WHO Drug Information Vol. 18, No. 2, 2004 - World Health ...

WHO Drug Information, Vol. 18, No. 2, 2004 Proposed INN: List 91
C30H47NO4S
H 3C
N
H
H
H
S
O
H3C H 2C
H
CH3 H H3C O
O
H
HO H H CH 3
224452-66-8
revaprazanum
revaprazan N-(4-fluorophenyl)-4,5-dimethyl-6-[(1RS)-1-methyl-
3,4-dihydroisoquinolin-2(1H)-yl]pyrimidin-2-amine
acid pump inhibitor
révaprazan N-(4-fluorophényl)-4,5-diméthyl-6-[(1RS)-1-méthyl-
3,4-dihydroisoquinoléin-2(1H)-yl]pyrimidin-2-amine
inhibiteur de la pompe à protons
revaprazán N-(4-fluorofenil)-4,5-dimetil-6-[(1RS)-1-metil-3,4-dihidroisoquinolin-
2(1H)-il]pirimidin-2-amina
inhibidor de la bomba de protones
C22H23FN4
CH3 H
N N
H 3C
N
CH 3
H
N
F
and enantiomer
et énantiomère
y enantiómero
199463-33-7
rilpivirineum
rilpivirine 4-{[4-({4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-
2-yl]amino}benzonitrile
antiviral
rilpivirine 4-[[4-[[4-[(1E)-2-cyanoéthényl]-2,6-diméthylphényl]amino]pyrimidin-
2-yl]amino]benzonitrile
antiviral
rilpivirina 4-[[4-[[4-[(1E)-2-cianoetenil]-2,6-dimetilfenil]amino]pirimidin-
2-il]amino]benzonitrilo
antiviral
C22H18N6
N
CH 3
CH 3
N
H
N
N
N
H
500287-72-9
CN
181